ZTS

#394
Zoetis Inc. Class A Common Stock
77.6 6 USD
-0.78%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
77.56
77.96
年范围
0.78
147.90
日变化
-0.78%
每月变动
-32.03%
6个月变化
-39.47%
年变化
-46.92%
前一天收盘价
78.2 7
Open
77.8 2
最低价
77.5 6
High
77.9 6
交易量
2 629
展开完整图表 完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 32.56 B
  • Employee 15 K
  • Founded N/A
  • CEO Kristin C. Peck
  • Website www.zoetis.com
  • Headquarter New Jersey, United States
  • FIGI BBG0039320N9
  • Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
19.38
市销率
5.44
每股股息
0.53
股息收益率 %
2.59

Zoetis Inc. Class A Common Stock

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

新闻